BIOATCTIVITY OF PHLORETIN FROM Syzgium polyanthum (WIGHT) WALP AS A GOUTY ARTHRITIS TREATMENT BASED ON SCREENING IN SILICO

Authors

  • Fernando Watung Universitas Negeri Manado
  • Musma Rukmana Universitas Negeri Manado
  • Hasmiati Hasmiati Universitas Negeri Manado
  • Tika Putri Agustina Universitas Negeri Manado
  • Margaret Pandaleke SMP Katolik St. Rafael Manado

DOI:

https://doi.org/10.53682/ibj.v4i2.7332

Keywords:

Gouty Arthritis, Phloretin, Screening In Silico, Syzgium polyanthum (Wight) Walp

Abstract

Gouty Arthritis is a disease caused by the accumulation of monosodium urate in the joints due to hyperuricemia, which causes painful inflammation. Syzgium polyanthum (Wight) Walp is a plant that grows in Indonesia and has been used as a traditional medicine.  It is used to treat various diseases, especially excessive production of uric acid. It is thought to contain phloretin compounds which can reduce the amount of uric acid. The purpose of this study was observed the biological activity of the natural products phloretin as an antihyperuricemia. Bioinformatic applications used in this study include the Pubchem compound database, protein target data base (Pharmmapper and Swiss Target Prediction), molecular docking software PyRx 0.8, software for 3D visualization and analysis of docking ligands and binding sites PyMOL and BIOVIA Disvovery Studo Client 2016.  The results of docking and binding site analysis showed that phloretin was able to interact with cyclin dependent kinase 2 (target protein) with a binding affinity of -6 kcal/mol more negatively than allopurinol with a binding affinity of -5.7, at different binding sites. Phloretin is a potential compound that can be used in the treatment of gouthy arthritis as an anti-inflammatory by inhibiting CDK2 activity.

References

Álvarez-Lario, B., & Macarrón-Vicente, J. (2010). Uric acid and evolution. Rheumatology, 49(11), 2010-2015.

Behzad, S., Sureda, A., Barreca, D., Nabavi, S. F., Rastrelli, L., & Nabavi, S. M. (2017). Health effects of phloretin: from chemistry to medicine. Phytochemistry reviews, 16, 527-533.

Fan, Y., Liu, W., Jin, Y., Hou, X., Zhang, X., Pan, H., & Guo, X. (2021). Integrated molecular docking with network pharmacology to reveal the molecular mechanism of simiao powder in the treatment of acute gouty arthritis. Evidence-Based Complementary and Alternative Medicine, 2021, 1-15.

George C, Minter DA. Hyperuricemia. [Updated 2023 Feb 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459218/

Gonzalez, E. B. (2012). An update on the pathology and clinical management of gouty arthritis. Clinical rheumatology, 31, 13-21.

Hartanti, L., Yonas, S. M. K., Mustamu, J. J., Wijaya, S., Setiawan, H. K., & Soegianto, L. (2019). Influence of extraction methods of bay leaves (Syzygium polyanthum) on antioxidant and HMG-CoA Reductase inhibitory activity. Heliyon, 5(4).

Hou, Chien W., Hsiao Fang H., Hua Wen F., Kee Ching J. (2012). Logan Seed Extarct Reduces Hyperuricema via Modulating Urate Transporter and Suppressing Xanthine Oxidase Activity. The American Journal of Chinese Medicine. 40(5): 979-991.

Hsu, A. Y., Wang, D., Liu, S., Lu, J., Syahirah, R., Bennin, D. A., & Deng, Q. (2019). Phenotypical microRNA screen reveals a noncanonical role of CDK2 in regulating neutrophil migration. Proceedings of the National Academy of Sciences, 116(37), 18561-18570.

Keenan, R. T. (2020, June). The biology of urate. In Seminars in arthritis and rheumatism (Vol. 50, No. 3, pp. S2-S10). WB Saunders.

Kusuma, I. W., Kuspradini, H., Arung, E. T., Aryani, F., Min, Y. H., Kim, J. S., & Kim, Y. U. (2011). Biological activity and phytochemical analysis of three Indonesian medicinal plants, Murraya koenigii, Syzygium polyanthum and Zingiber purpurea. Journal of Acupuncture and Meridian Studies, 4(1), 75-79.

Laphanuwat, P., & Jirawatnotai, S. (2019). Immunomodulatory roles of cell cycle regulators. Frontiers in cell and developmental biology, 7, 23.

Lelono, R. A., Tachibana, S., & Itoh, K. (2009). In vitro antioxidative activities and polyphenol content of Eugenia polyantha Wight grown in Indonesia. Pakistan journal of biological sciences: PJBS, 12(24), 1564-1570.

Lipinski Christopher A., Franco L., Beryl W. D., Paul F. F. (2001). Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Advanced Drug Delivery Reviews. 46(2001): 3-26.

Liu, S., Yujia Y., Yijie Z., Meng Z., Younan C., Jingqiu C., Yanrong L., Jingping L. (2017). Phloterin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake. J. Cell. Mol. Med. 20(10): 1-10.

Malumbres, M. (2014). Cyclin-dependent kinases. Genome biology, 15(6), 1-10.

Mariadoss, A. V., Vinyagam, R., Rajamanickam, V., Sankaran, V., Venkatesan, S., & David, E. (2019). Pharmacological aspects and potential use of phloretin: A systemic review. Mini reviews in medicinal chemistry, 19(13), 1060-1067.

Muhtadi., Andi Suhedi, Nurcahyanti W., E. M. Sutristna. (2012). Potensi Daun Salam (Syzigium polyanthum Walp.) dan Biji Jinten Hitam (Nigella sativa Linn) sebagai Kandidat Obat Herbal terstandar Asam Urat. Pharmacon. 13(1): 30-36.

Pacher, P., Aelx N., Csaba S. (2006). Therapeutic Effects of Xhantine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol. Pharmacole Rev.58(1): 87-114.

Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castañeda-Sanabria, J., & Bardin, T. (2017). 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the rheumatic diseases, 76(1), 29-42.

So, A., & Thorens, B. (2010). Uric acid transport and disease. The Journal of clinical investigation, 120(6), 1791-1799.

Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2012). Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis & Rheumatism, 64(8), 2529-2536.

V., Igor R., Caroline H., Nicola K G., James F., Colin NA P., Sara A K., Ivana K., Ozren P., Juergen G., James F W., Anthony M., Philip L R., Xinhua S., Branka J., Nina S., Barbara G., Joanne M., Susan C., Zrinka B., Lovorka B., Marijana P., Irena Martinovic K., Lina Z., Tatjana S., Sarah H W., William A R., Peter H., Charley H K., Albert T., Louise A D., Lynette D F., Martin A., Paul M McK., Stuart H R., Andrew D M., Pavao R., Nicholas D H., Harry C., Alan F W. (2008). SLC2A9 is a newly indentified urate transporter influenscing serum urate concentration, urate excrerion and gout. Nature Genetics. 40(4): 437-442.

Watson & Pessiesn, 2001 Watson, R. T., Pessien J. E. (2001). Intracellular organization of insulin signaling and GLUT 4 translocation. Prog. Horm. Res. 56:179-193.

Widyawati, T., Purnawan, W. W., Atangwho, I. J., Yusoff, N. A., Ahmad, M., & Asmawi, M. (2015). Anti-diabetic activity of Syzygium polyanthum (Wight) leaf extract, the most commonly used herb among diabetic patients in Medan, North Sumatera, Indonesia.

Wu, X. W., Lee, C. C., Muzny, D. M., & Caskey, C. T. (1989). Urate oxidase: primary structure and evolutionary implications. Proceedings of the National Academy of Sciences, 86(23), 9412-9416.

Yin, H., Liu, N., & Chen, J. (2022). The Role of the Intestine in the Development of Hyperuricemia. Frontiers in immunology, 13, 845684.

Zahroh, C., & Faiza, K. (2018). Pengaruh kompres hangat terhadap penurunan nyeri pada penderita penyakit Artritis Gout. Jurnal Ners Dan Kebidanan (Journal of Ners and Midwifery), 5(3), 182-187.

Downloads

Published

2023-08-31

How to Cite

Watung, F., Rukmana, M., Hasmiati, H., Agustina, T. P., & Pandaleke, M. (2023). BIOATCTIVITY OF PHLORETIN FROM Syzgium polyanthum (WIGHT) WALP AS A GOUTY ARTHRITIS TREATMENT BASED ON SCREENING IN SILICO. Indonesian Biodiversity Journal, 4(2), 39 - 47. https://doi.org/10.53682/ibj.v4i2.7332

Issue

Section

Articles